First Tracks Analyst Price Targets

Wall Street analyst price targets and consensus rating for First Tracks (TRAX).

Price Target Range — 2 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingOverweight# Analysts8Avg. Consensus PT$61Upside to Avg. PT+65.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 3, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$57
Aug 13, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$54→$95
Aug 13, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$48→$65
Aug 13, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$60→$70
Aug 13, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$44→$57
Aug 10, 2026	UBS	Michael Yee	PT Raise	Buy	$45→$65
Jul 28, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$30→$60
Jul 28, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$30→$55
Jul 21, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$40→$48
Jul 10, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$30→$44
Jul 8, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$30
Jun 8, 2026	Wells Fargo	Derek Archila	Initiate	Overweight	$30
May 4, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$54
Apr 28, 2026	HC Wainwright & Co.	Emily Bodnar	Initiate	Buy	$30
Apr 24, 2026	Leerink Partners	David Risinger	Initiate	Outperform	$46
Apr 23, 2026	JP Morgan	Anupam Rama	Initiate	Overweight	$31
Apr 22, 2026	Barclays	Etzer Darout	Initiate	Overweight	$40
Apr 21, 2026	UBS	Michael Yee	Initiate	Buy	$45

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates First Tracks (NASDAQ:TRAX) with a Buy and maintains $57 price target.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

Barclays analyst Etzer Darout maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $48 to $65.

Benzinga Newsdesk

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.

Avi Kapoor

PRO
Wedbush Maintains Outperform on First Tracks, Raises Price Target to $70

Wedbush analyst Martin Fan maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $60 to $70.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on First Tracks, Raises Price Target to $95

Piper Sandler analyst Yasmeen Rahimi maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $54 to $95.

Benzinga Newsdesk

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.

Avi Kapoor

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

PRO
Wedbush Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Piper Sandler Maintains Overweight on First Tracks, Raises Price Target to $95

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

People Also Watch

People Also Watch

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PROBarclays Maintains Overweight on First Tracks, Raises Price Target to $65

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

PROWedbush Maintains Outperform on First Tracks, Raises Price Target to $70

PROPiper Sandler Maintains Overweight on First Tracks, Raises Price Target to $95

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

PRO
Wedbush Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Piper Sandler Maintains Overweight on First Tracks, Raises Price Target to $95